DIABETES TYPE 2 - Nursing Case Study
Pathophysiology
• Primary mechanism: Insulin resistance - Body cells, particularly muscle and fat tissues, fail to respond effectively to insulin, leading to decreased glucose uptake and increased blood glucose levels. This resistance is often associated with obesity, where excess fatty acids and inflammatory cytokines impair insulin signaling pathways.
• Secondary mechanism: Pancreatic beta-cell dysfunction - Over time, the pancreas cannot compensate for insulin resistance by producing enough insulin. The beta cells become impaired due to chronic overstimulation and increased demands, eventually leading to decreased insulin secretion.
• Key complication: Hyperglycemia - Persistent elevated blood glucose levels can lead to microvascular complications such as retinopathy, nephropathy, and neuropathy, as well as macrovascular complications like cardiovascular disease, highlighting the importance of early detection and management.
Patient Profile
Demographics:
56 years old, female, school teacher
History:
• Key past medical history: Diagnosed with Type 2 Diabetes 8 years ago, hypertension, hyperlipidemia
• Current medications: Metformin 1000 mg twice daily, Lisinopril 10 mg once daily, Atorvastatin 20 mg once daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent fatigue and occasional blurred vision
• Key symptoms: Increased thirst, frequent urination, tingling in feet
• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, blood glucose level 180 mg/dL
Section 1
During the follow-up clinic visit, the patient's symptoms of persistent fatigue and blurred vision prompted further diagnostic testing to evaluate the progression of her diabetes and any potential complications. The laboratory tests revealed an HbA1c level of 8.6%, indicating poor long-term glycemic control. Additionally, a microalbuminuria test showed elevated levels of albumin in the urine, suggesting early signs of diabetic nephropathy. An ophthalmology referral confirmed the presence of non-proliferative diabetic retinopathy, characterized by microaneurysms and mild retinal hemorrhages.
Clinically, the patient exhibited decreased protective sensation in her feet upon monofilament testing, raising concern for diabetic neuropathy. This sensory loss, combined with the patient's tingling sensations, increases her risk for foot ulcers, underlining the importance of patient education on foot care and regular podiatric evaluations. Given her blood pressure reading of 145/90 mmHg and history of hypertension, there is a heightened risk for further cardiovascular complications, suggesting the need for more aggressive blood pressure management.
The healthcare team emphasizes the importance of lifestyle modifications, including dietary changes and increased physical activity, to improve insulin sensitivity and overall metabolic control. A potential adjustment in her medication regimen is considered, possibly incorporating a GLP-1 receptor agonist to address both hyperglycemia and weight management. These findings necessitate close monitoring and a comprehensive, multidisciplinary approach to prevent progression of her diabetic complications and improve her quality of life.
Section 2
Several weeks following the initial follow-up visit, the patient returns to the clinic with concerns of increased swelling in her lower extremities and a noticeable increase in weight despite adherence to dietary recommendations. Upon assessment, her weight has increased by 5 pounds since her last visit, and she exhibits pitting edema in both legs. Her blood pressure remains elevated at 150/92 mmHg. Considering these new findings, the healthcare team orders a series of tests to evaluate the patient's fluid status and potential cardiac involvement.
The laboratory results reveal a serum creatinine level of 1.8 mg/dL, higher than her baseline, indicating a worsening renal function. Additionally, her serum albumin level is slightly decreased, suggesting potential fluid overload. A B-type natriuretic peptide (BNP) test is performed, and the results show an elevated level of 550 pg/mL, raising concerns for possible heart failure. These findings suggest that the patient's hypertension and diabetes-related nephropathy may be contributing to early signs of heart failure, necessitating a re-evaluation of her current treatment plan.
Given the complexity of her case, the healthcare team decides to refer the patient to a cardiologist for further evaluation and management. They also discuss the possibility of initiating an angiotensin receptor blocker (ARB) to better manage her hypertension and provide renal protection. The patient is educated on recognizing signs of worsening heart failure and the importance of adhering to a low-sodium diet to help manage her fluid status. This new development underscores the need for an integrated approach to address her multifaceted health challenges, highlighting the interconnected nature of diabetes complications and cardiovascular health.
Section 3
In the weeks following the referral to the cardiologist, the patient begins a new medication regimen that includes an angiotensin receptor blocker (ARB) to address her hypertension and provide renal protection. Despite these changes, the patient returns to the clinic with new complaints of increased shortness of breath, particularly at night, and a persistent cough. Upon examination, her vital signs show a blood pressure of 148/90 mmHg, a heart rate of 96 beats per minute, and a respiratory rate of 22 breaths per minute. Auscultation of her lungs reveals bilateral basal crackles, indicative of fluid accumulation. She also reports a continued increase in weight, an additional 3 pounds since her last visit, and persistent pitting edema in her lower extremities. These findings suggest worsening fluid overload and potential progression of heart failure.
The healthcare team orders additional diagnostic tests to further evaluate the patient's current condition. A repeat BNP test shows a level of 680 pg/mL, indicating a significant increase from her previous results and reinforcing the suspicion of exacerbated heart failure. An echocardiogram is performed, revealing a reduced ejection fraction of 40%, which confirms the decline in her cardiac function. Her serum electrolytes show a slight decrease in sodium levels at 133 mmol/L, aligning with her symptoms of fluid retention and dilutional hyponatremia. These results prompt a reassessment of her treatment plan, emphasizing the need to optimize her heart failure management.
In response to these developments, the healthcare team considers the introduction of a diuretic to help alleviate her symptoms of fluid overload and improve her respiratory status. The patient is counseled on the importance of daily weight monitoring, strict adherence to a low-sodium diet, and recognizing early symptoms of heart failure exacerbation. This ongoing management highlights the intricate balance required to address her diabetes, renal function, and cardiac health, urging a proactive and coordinated approach to prevent further complications.
Section 4
In the days following the initiation of diuretic therapy, the patient returns for a follow-up appointment. She reports some improvement in her shortness of breath and a decrease in her nighttime cough. However, she continues to experience significant fatigue and notes a new sensation of palpitations, which seem to occur sporadically throughout the day. During the clinical assessment, her vital signs reveal a blood pressure of 140/88 mmHg, heart rate of 110 beats per minute with irregularities, and a respiratory rate of 20 breaths per minute. Her lung auscultation still reveals mild bilateral crackles, though less pronounced than before, suggesting a partial response to the diuretic intervention.
The healthcare team, concerned about the irregular heart rate, conducts an electrocardiogram (ECG), which reveals the presence of atrial fibrillation, a common arrhythmia associated with heart failure and increased cardiac workload. The presence of atrial fibrillation introduces a new layer of complexity to her condition, requiring careful consideration of anticoagulation therapy to reduce the risk of thromboembolic events, particularly given her diabetes and hypertension.
Addressing this new complication, the healthcare team discusses the addition of a rate-controlling medication to manage her atrial fibrillation and potentially initiate anticoagulant therapy. The patient is educated on recognizing symptoms of arrhythmia exacerbation and the importance of adherence to her medication regimen. This new development showcases the interconnectedness of her cardiovascular, renal, and endocrine systems, necessitating a comprehensive and coordinated treatment strategy to manage her multifaceted health concerns effectively. The patient is scheduled for regular follow-up visits to closely monitor her cardiac rhythm, electrolyte balance, and overall response to the adjusted treatment plan.
Section 5
Several weeks after initiating the new treatment plan, the patient returns for another follow-up appointment. She reports a moderate improvement in her energy levels and a noticeable reduction in the frequency of palpitations. However, she has begun experiencing occasional episodes of dizziness and a general sense of weakness, particularly in the late afternoon. During the clinical assessment, her blood pressure is recorded at 130/85 mmHg, heart rate at 78 beats per minute, and respiratory rate at 18 breaths per minute. While these vital signs suggest some stabilization, her symptoms prompt further investigation.
A repeat ECG confirms the presence of controlled atrial fibrillation, but laboratory tests reveal a serum potassium level of 3.2 mmol/L, which is below the normal range. This hypokalemia is likely a side effect of the diuretic therapy, which has been effective in managing her fluid overload but has also led to electrolyte imbalances. The healthcare team recognizes the critical need to address this complication to prevent further cardiac issues and to enhance her overall treatment efficacy.
In response, the team adjusts her diuretic dosage and introduces a potassium supplement to correct the imbalance. The patient is counseled on dietary modifications to include potassium-rich foods and is educated on the signs of both low and high potassium levels. This adjustment underscores the importance of a nuanced approach to managing her interconnected health issues, highlighting the need for ongoing monitoring and collaborative care. The patient is scheduled for more frequent laboratory assessments to ensure that her electrolyte levels stabilize, and her symptoms are closely monitored to evaluate her response to the updated treatment regimen.